Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Pila Pharma’s CEO comments on the Q2 report

Malmö-based biotech company Pila Pharma advances towards clinical phase II studies with XEN-D0501 at a steady pace. During the second quarter of 2022 the company announced plans to enter a new indication with the drug candidate. BioStock asked the company’s CEO Dorte X. Gram about her views on the second quarter and about the plans ahead.Read the full article at biostock.se: https://www.biostock.se/en/2022/08/pila-pharmas-ceo-comments-on-the-q2-report/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Smoltek publishes operational update for its Semiconductors business area

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the group company Smoltek Semi AB (“Smoltek Semi”) has made significant progress in the development of the technology for ultra-thin capacitors during the year. The recently announced collaboration agreement with the Yageo Group, one of the world’s largest capacitor manufacturers, is expected to further accelerate the industrialization of Smoltek’s ultra-thin capacitors. This is in line with the goal to be able to

Eurocine Vaccines´ newly added HSV-2 vaccine candidate gains patent protection in South Korea

Eurocine Vaccines has received a Notice of Decision to Grant from the Korean Intellectual Property Office, covering inventions relevant for the newly added vaccine candidate against HSV-2, Herpes Simplex Virus Type 2. Adding South Korea to the territories with granted patents is well in line with the company´s global patent strategy as it is considered one of the four most important pharmaceutical markets in Asia.The received Notice of Decision to Grant not only provides strengthened protection for the technology, but it also validates the level of innovation for the innovation. The patent

Truecaller launches vastly improved iPhone App

Truecaller, the world’s leading global communications platform, has launched a brand-new version of their iPhone app for users around the world. The iOS app has been completely re-written from the ground up to be lighter, more efficient, and most important of all, it offers significantly better number identification, spam-, scam- and business call identification compared to previous versions of the app. The new app offers up to 10 times better spam- and business identification compared to the previous versionThis change has been brought about by an all-new architecture that leverages

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B635TG28 Issuer Name ENQUEST PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Cobas Asset Management, SGIIC, S.A. City of registered office (if applicable) Madrid Country of registered office (if applicable) Spain 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation,

Industrial Solar launches a website with refreshed design and content

Industrial Solar, a 100% subsidiary of Clean Industry Solutions, launched a renewed website with a brand-new look and expanded content. Industrial Solar provides expertise and technology for industrial clients to implement solar energy solutions. The new website reflects Industrial Solar’s holistic approach to solar energy solutions.Industrial Solar’s website has been restored with a fresher and sleeker look in design and more functionality. For instance, visitors can now conduct an in-site search to find more specific information faster. Apart from the usual English and German sites,

Trevian invests alongside Partners Group in large-scale logistics real estate transaction – Trevian will act as asset manager and grow the portfolio further

Trevian acted as the buyer's advisor for the purchase, by private markets investment manager Partners Group, of the SaKa Hallikiinteistöt real estate portfolio in Finland. The portfolio contains 140,000 m2 of real estate in Finland's most central logistics and industrial areas. Trevian will manage the portfolio post acquisition, and the parties aim to grow the portfolio further. Logistics are an attractive and sought-after sector in the real estate investment industry.The SaKa portfolio transaction, which includes a total of 20 properties, is one of the largest in Trevian’s history.

Valtech Unveils Readiness Assessment to Develop Salesforce Composable Commerce Architectures

New Valtech Readiness Assessment is the first solution that helps brands assess the business opportunities and implement the new Salesforce Composable StorefrontValtech , a global business transformation agency, today announced the release of Valtech’s Salesforce Composable Storefront Readiness Assessment, a 30-aspect evaluation, which empowers existing Salesforce Commerce Cloud

Automated planning frees resources at Moelven

In optimizing the production of glued wooden beams, as much material as possible must be glued at the same time. Together with Prevas, Moelven in Töreboda is developing a web-based system that automates the time-consuming planning activities for glue pressing.[En bild som visar person Automatiskt genererad beskrivning] “Our employees are knowledgeable of production,” says Niklas Lindh, production manager at Moelven in Töreboda. “By investing in automation, we can better utilize their skills and experience.” Moelven in Töreboda manufactures glued wooden beams for three customer sectors –

Orthex Corporation: Managers’ Transactions – Sanna Suvanto-Harsaae

Orthex Corporation, Managers’ transactions, 30 August 2022 at 10.30 a.m. EEST_______________________________________Person subject to the notification requirementName: Sanna Suvanto-HarsaaePosition: Chair of the BoardIssuer: Orthex CorporationLEI: 7437008RMK8BSWN39T09Notification type: INITIAL NOTIFICATION_______________________________________Transaction date: 2022-08-29Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000480504Nature of the transaction: ACQUISITIONTransaction details(1): Volume: 232 Unit price: 4.99 EUR(2): Volume: 968 Unit

Dentalum Operations AB (publ) publishes half year report, January -June 2022

Maintained profitability and continued growthSecond quarter, April - June 2022 · Operating revenue increased by 72.8 % to SEK 85.8 million (49.7). · EBITDA amounted to SEK 24.4 million (12.6) · Net earnings amounted to SEK 4.8 million (-0.4). · Operating cash flow amounted to SEK 25.3 million (12.6). Net cash flow totalled SEK – 46.7 million (-64.0). · Total equity amounts to SEK 262.0 million (101.5), cash balance of SEK 198.6 million (110.5) and interest-bearing debt of SEK 397.7 million (300.3). · During the period Dentalum acquired three (3) clinics with annual

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 169 - 30 AUGUST 2022 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

FluoGuide receives permission to start phase IIb trial in aggressive brain cancer

Copenhagen, Denmark, 30 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the company now has received the permission to start the phase IIb clinical trial with FG001.FluoGuide has now received approval from the Danish Ethical Committee and the trial can start in Denmark. FluoGuide announced in April FG001’s highly promising results in aggressive brain cancer (high grade glioma) following its phase I/IIa trial. FG001 was demonstrated to be well tolerated with only few patients reporting mild side effects (3 out of 40 patients). Furthermore, 100% of

Professor Kevin Eva is awarded the Karolinska Institutet Prize for Research in Medical Education

Prof. Kevin Eva is awarded the 2022 Karolinska Institutet Prize for Research in Medical Education (KIPRIME). Prof. Eva is Associate Director and Senior Scientist in the Centre for Health Education Scholarship, and Professor and Director of Educational Research and Scholarship in the Department of Medicine, at the University of British Columbia. He is also Editor-in-Chief of the journal Medical Education. Professor Eva’s work has greatly advanced health professions education research in many key areas and had a profound effect on an entire generation of educators and researchers.Professor

Cysec and Avassa partner up for automated, scalable, and secure edge computing environments

LAUSANNE, SWITZERLAND. and STOCKHOLM, SWEDEN. Cysec, a software provider for confidential computing, and Avassa, an edge application orchestration platform provider, enter a partnership to offer automated, scalable, and secure solutions for edge computing environments.For many enterprises today, it’s no longer a matter of cloud or edge — it’s a matter of both. And with a hybrid infrastructure, businesses need to apply tooling to stay innovative and efficient in both centralized and distributed environments. Cysec, a software provider for confidential computing, and Avassa, an edge

Platinum Egg brings popular Japanese Web 3.0 game to Concordium

August 30 - Zug, Switzerland - Tokyo, Japan -  Platinum Egg, the popular Japanese game company, has announced the upcoming integration of its Web 3.0 game, CrossLink , with the Concordium Blockchain.   With this partnership, Platinum Egg is making it easier for people with low cryptocurrency literacy to feel safe when joining the crypto space. “Another aspect of cryptocurrencies that has been preventing its widespread integration in Japan has been the perception of lack of security. A history of strict banking laws and regulations has created a

Altor supports H2 Green Steel on EUR 190 million funding round

Altor Fund V (Altor) continues to support the Swedish green impact company H2 Green Steel in its first close of the Series B equity financing. The key investors in the financing round next to Altor are AMF, GIC, Schaeffler, Swedbank Robur and Vargas Holding. Existing shareholders continue to support the company with additional equity funding, including such investors as Kingspan, FAM, Marcegaglia, IMAS Foundation, Cristina Stenbeck and Daniel Ek.Altor was also part of the initial Series A equity financing in March 2021.H2 Green Steel was founded in 2020 with the ambition to accelerate the

Changes in SkartaNYAB Plc's Executive Management Team

SkartaNYAB PlcCOMPANY ANNOUNCEMENT30 August 2022 at 10:00Changes in SkartaNYAB Plc’s Executive Management Team SkartaNYAB Plc has decided to reorganize management structures of the Finnish business operations of the group. Mikael Ritola starts as the Senior Vice President Finland as of 1 October 2022. He has previously been a member of the Executive Management Team of the group as Vice President Sweden, being responsible for special construction business in Sweden. Ritola is also a member of SkartaNYAB Plc’s Board of Directors. Mikko Ahonen, the previous Senior Vice President

Eficode achieves HashiCorp Specialized partner and Certified HashiCorp Implementation Partner statuses

Helsinki, August 30, 2022 - Eficode  has achieved HashiCorp Specialized partner status, and has also become a Certified HashiCorp Implementation Partner for HashiCorp Terraform and Vault. The partnership helps Eficode’s customers adopt a cloud operating model, upskill development teams, and move to modern cloud-based software development.Eficode offers HashiCorp Vault as part of its Eficode ROOT managed DevOps platform . Eficode customers have already included technologies from HashiCorp in their DevOps toolchains. Eficode also has

Read original

Scandion Oncology announce change to its Executive Management

Maj Hedtjärn has decided to resign from her position as Chief Operating Officer and Head of R&D Operations. She will leave Scandion Oncology no later than December 31, 2022.Scandion Oncology (Scandion), a biotech company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options, announces that Maj Hedtjärn, Chief Operating Officer, Head of R&D Operations and member of Executive Management, has decided to resign from her position to pursue new opportunities outside Scandion. Maj Hedtjärn will leave Scandion no later than December 31, 2022,

SkartaNYAB Plc's half-yearly report 1 January-30 June 2022: Profitable growth in Sweden - challenges in Finland

SkartaNYAB PlcCOMPANY ANNOUNCEMENT30 August 2022 at 09:55SkartaNYAB Plc’s half-yearly report 1 January–30 June 2022: Profitable growth in Sweden – challenges in Finland · The first combined quarter of Skarta and NYAB proved the successful merger of two Nordic companies, as good performance of Swedish business operations compensated challenges experienced in Finnish operations · The company has started measures to improve profitability in Finland during the rest of the year by utilizing practices that have been successful in Sweden, and is confident about successful future of the

Major shareholder announcement

Company announcement 36/2022 In accordance with section 30 of the Capital Markets Act, HusCompagniet A/S (the “Company”) hereby announces that Handelsbanken Fonder AB has notified the Company that Handelsbanken Fonder AB, directly and indirectly, holds less than 5.00% of the voting rights and shares in the Company. For additional information, please contact: HusCompagniet Cristina Rønde Hefting, Head of IR & Press                                                               +45 51 96 23 14 Information on HusCompagniet HusCompagniet is a leading provider of single-family

OmniCar Holding AB: OmniCar Holding AB: Omnicar Holding Q2 2022 report

Please find attached our Q2 2022 report Our ambitious growth plan continues to provide results with OmniCar reporting its strongest growth in the history of the company. · During the second quarter of 2022, revenue increased 260% sequentially to 21.1 million SEK from 5.9 million SEK in the first quarter of this year  · 383% revenue increase compared to Q2 2021 · OmniCarService continues its growth with revenue increasing 24% sequentially vs. 1Q22 and 125% YoY Investments in our technology, employees, and marketing are the driving force behind our growth this year. We will

Cantargia publishes preclinical data on strong anti-tumor efficacy of nadunolimab in combination with chemotherapy

Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported publication of preclinical results demonstrating that Cantargia’s lead candidate, the IL1RAP-binding antibody nadunolimab (CAN04), shows synergistic anti-tumor efficacy with chemotherapy through a mechanism likely to be highly relevant in the clinical situation. The effect is dependent on the unique capability of nadunolimab to simultaneously block both the alpha and beta forms of interleukin-1 (IL-1). These findings support the promising clinical interim data observed with nadunolimab in pancreatic cancer (PDAC) and non-small

There are no items matching the current filter
There are no more items matching the current filter
Back to top